Sectors
Industry Focus
Deep sector expertise is non-negotiable in Japan. We focus on industries where the intersection of global innovation and Japanese structural complexity is most profound.
Technology & Enterprise SaaS
Japan is currently undergoing a massive, albeit cautious, wave of Digital Transformation (DX). The opportunity for B2B SaaS and enterprise software is vast, driven by an aging workforce and the need for efficiency. However, foreign tech firms often fail by underestimating the demand for extreme customization, localized UI/UX, and flawless, high-touch customer support.
We help tech companies adapt their sales motions from a 'self-serve' Western model to the relationship-heavy, proof-of-concept-driven Japanese enterprise sales cycle.
Advanced Manufacturing & Logistics
Japan's legacy as a manufacturing powerhouse (Monozukuri) remains strong. Entering this space requires penetrating dense, long-standing supplier networks (Keiretsu). Quality standards are uncompromising, and cost is often secondary to reliability and long-term partnership.
We assist industrial and logistics firms in navigating these closed ecosystems, identifying joint venture opportunities, and establishing the deep trust required to become a certified supplier.
Retail, Luxury & Consumer Goods
The Japanese consumer is famously discerning, demanding high quality, perfect packaging, and impeccable service (Omotenashi). The retail landscape is heavily fragmented, and distribution channels are notoriously complex, often involving multiple layers of wholesalers.
We provide granular consumer insights and develop omnichannel distribution strategies that respect the power of traditional retail networks while capturing the growing e-commerce segment.
Healthcare & Life Sciences
With a rapidly aging population, Japan is the world's second-largest healthcare market. It is also one of the most highly regulated. Navigating the PMDA (Pharmaceuticals and Medical Devices Agency) requires specialized knowledge and strategic patience.
We help pharmaceutical, medical device, and digital health companies craft regulatory engagement strategies, assess market potential under the NHI (National Health Insurance) pricing system, and establish critical local partnerships.
